Infections and Defects in Mechanisms of Defense

ABO blood group

Acquired immunodeficiency syndrome (AIDS)

Acute rejection

Adenosine deaminase (ADA) deficiency

Agammaglobulinemia

Allergen

Allergy

Alloimmune disease

Alloimmunity

Anaphylaxis

Ankylosing spondylitis

Antibiotic resistance

Antibody-dependent cell-mediated cytotoxicity (ADCC)

Antigenic drift

Antigenic shift

Antiretroviral therapy (ART)

Antitoxin

Arthus reaction

Atopic

Attenuated virus

Autoimmune disease

Autoimmunity

β-lactamase

Bacteremia

Bare lymphocyte syndrome

Biofilms

Blood group antigen

Bruton agammaglobulinemia

C3 deficiency

CCR5 antagonist

Chronic granulomatous disease (CGD)

Chronic mucocutaneous candidiasis

Chronic rejection

Communicability

Complement deficiency

Contact dermatitis

Cryoglobulins

Defects in innate immunity

Delayed hypersensitivity reaction

Delayed hypersensitivity skin test

Dermatophyte

Desensitidation

DiGeorge syndrom

Dimorphic fungus

Endotoxic shock

Endotoxin

Erythema

Exotoxin

Graft-versus-host disease

Herd immunity

HIV integrase

HIV integrase inhibitor

HIV fusion inhibitor

HIV protease

HIV protease inhibitor

Human immunodeficiency virus (HIV)

Human leukocyte antigen (HLA)

Hyperacute rejection

Hypersensitivity

Hypogammaglobulinemia

Immediate hypersensitivity reaction

Immune deficiency

Immunogenicity

Induration

Infectivity

Isohemagglutinin

Major histocompatibility complex (MHC)

Mannose-binding lectin deficiency

Mesenchymal stem cell (MSC)

Methicillin-resistant Staphylococcus aureus (MRSA)

Multiple-antibiotic resistance

Mycosis

Parasitic microorganisms

Passive immunotherapy

Pathogenicity

Phagocytic defects

Portal of entry

Predominantly antibody deficiency

Primary immune deficiency

Raynaud phenomenon

Reverse transcriptase

Reverse transcriptase inhibitor

Rh blood group

Secondary immune deficiency

Selective IgA deficiency

Septicemia

Semus sickness

Severe combined immunodeficiency (SCID)

Severe congenital neutropenia

Systemic lupus erythematosus (SLE)

Tissue-specific antigen

Tolerance

Toxigenicity

Toxoid

Type I hypersensitivity

Type II hypersensitivity

Type III hypersensitivity

Type IV hypersensitivity

Universal donor

Universal recipient